Marked intrafamilial phenotypic variation in a family with SOD1 C111Y mutation

References

• Lowe J, Lennox G, Leigh PN. Disorders of movement and system degeneration. In: Graham DI, Lantos PL, editors. Greenfield's Neuropathology. 6th edn. Vol 2. London: Edward Arnold; 1992. pp 320–30.
   Google Scholar
• Deng HX, Hentati A, Tainer JA, Iqbal Z, Cayabyab A, Hung WY, . Amyotrophic lateral sclerosis and structural defects in Cu/Zn superoxide dismutase. Science. 1993; 261:1047–51.
   PubMed Web of Science ®Google Scholar
• Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, . Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993;362:59–62.
   PubMed Web of Science ®Google Scholar
• ALS Online Genetic Database, ALSoD; http://alsod.iop.kcl.ac.uk
   Google Scholar
• Cudkowicz ME, McKenna-Yasek D, Sapp PE, Chin W, Geller B, Hayden DL, . Epidemiology pf mutations in superoxide dismutase in amyotrophic lateral sclerosis. Ann Neurol. 1997;41:210–21.
   PubMed Web of Science ®Google Scholar
• Nakano T, Tsukada N, Yanagisawa N, Tsukagoshi H, Nakamura T. Familial motor neuron disease with cases of amyotrophic lateral sclerosis and spinal muscular atrophy. Clin Neurol (Tokyo). 1985;25:1119–25.
   PubMedGoogle Scholar
• Eisen A, Mezei MM, Stewart HG, Fabros M, Gibson G, Andersen PM. SOD1 gene mutations in ALS patients from British Columbia, Canada: clinical features, neurophysiology and ethical issue in management. Amyotroph Lateral Scler. 2008;9:108–19.
   PubMed Web of Science ®Google Scholar
• Sumi H, Kato S, Mochimaru Y, Fujimura H, Etoh M, Sakoda S. Nuclear TAR DNA binding protein 43 expression in spinal cord neurons correlates with the clinical course in amyotrophic lateral sclerosis. J Neuropathol Exp Neurol. 2009;68:37–47.
   PubMedGoogle Scholar
• de Carvallo M, Dengler R, Eisen A, England JD, Kaji R, Kimura J, . Electrodiagnostic criteria for diagnosis of ALS. Clin Neurophysiol. 2008;119:497–503.
   PubMedGoogle Scholar
• Yulug IG, Katsanis N, de Belleroche J, Collinge J, Fisher EM. An improved protocol for analysis of SOD1 gene mutations, and a new mutation in exon 4. Hum Mol Genet. 1995;4:1101–4.
   PubMedGoogle Scholar
• Ohi T, Saita K, Takeuchi S, Nabeshima K, Tashiro H, Shiomi K, . Clinical features and neuropathological findings of familial amyotrphic lateral sclerosis with a His46Arg mutation in Cu/Zn superoxide dismutase. J Neurol Sci. 2002;197:73–8.
   PubMed Web of Science ®Google Scholar
• Weber M, Neuwirth C, Thierbach J, Schweilkert K, Czaplinski A, Petersen J, ALS patients with SOD1 mutations in Switzerland show very diverse phenotypes and extremely long survival. J Neurol Neurosurg Psychiatry. 2012;83:351–3.
   PubMed Web of Science ®Google Scholar
• Meyer T, Schwan A, Dullinger JS, Brocke J, Hoffmann KT, Nolte CH, . Early-onset ALS with long-term survival associated with spastin gene mutation. Neurology. 2005; 65:141–3.
   PubMed Web of Science ®Google Scholar
• Leigh PN. Amyotrphic lateral sclerosis. In: Eisen AA, Shaw PJ, editors. Motor Neuron Disorders and Related Diseases, Handbook of Clinical Neurology. Vol. 82 (3rd series). Amsterdam: Elsevier BV; 2007: pp 252–7.
   Google Scholar
• Ohi T, Nabeshima K, Kato S, Yazawa S, Takeuchi S. Familial amyotrophic lateral sclerosis with His-46Arg mutation in Cu/Zn superoxide dismutase presenting characteristic clinical features and Lewy body-like hyaline inclusions. J Neurol Sci. 2004;225:19–25.
   PubMed Web of Science ®Google Scholar
• Aoki M, Ogasawara M, Matsubara Y, Narisawa K, Nakamura S, Itoyama Y, . Familial amyotrophic lateral sclerosis (ALS) in Japan associated with H46R mutation in Cu/Zn superoxide dismutase gene: a possible new subtype of familial ALS. J Neurol Sci. 1994;126:77–83.
   PubMed Web of Science ®Google Scholar
• Abe K, Aoki M, Ikeda M, Watanabe M, Hirai S, Itoyama Y. Clinical characteristics of familial amyotrophic lateral sclerosis with Cu/Zn superoxide dismutase gene mutations. J Neurol Sci. 1996;136:108–16.
   PubMed Web of Science ®Google Scholar
• Syriani E, Morales M, Gamez J. The p.E22G mutation in the Cu/Zn superoxide dismutase gene predicts a long survival time: clinical and genetic characterization of a seven-generation ALS1 Spanish pedigree. J Neurol Sci. 2009; 285:46–53.
   PubMed Web of Science ®Google Scholar
• Gamez J, Corbera-Bellalta M, Nogales G, Ranguer N, Garcia-Arumi E, Badia-Canto M, . Mutation analysis of the Cu/Zn superoxide dismutase gene in a Catalan ALS population: should all sporadic ALS cases also be screened for SOD1? J Neurol Sci. 2006;247:21–8.
   PubMed Web of Science ®Google Scholar
• Regal L, Vanopdenbosch L, Tilkin P, van den Bosch L, Thijs V, Sciot R, . The G93C mutation superoxide dismutase 1: clinicopathologic phenotype and prognosis. Arch Neurol. 2006;63:262–7.
   PubMedGoogle Scholar
• Restagno G, Lombardo F, Sbaiz L, Mari C, Cellera C, Alimonti D, Amyotoroph Lateral Scler. 2008;9:35–9.
   Google Scholar
• Campbell MJ, Lane RJM, de Belleroche JS. The rare G93D mutation causes a slowly progressing lower motor neuron disease. Familial amyotrophic lateral sclerosis with a point mutation of SOD1: intrafamilial heterogeneity of disease duration associated with neurofibrillary tangles. J Neurol Neurosurg Psychiatry. 1995;59:266–70.
   PubMedGoogle Scholar
• Orell RW, Habgood JJ, Malaspina A, Mitchell J, Greenwood J, Lane RJM, . Clinical characteristics of SOD1 gene mutation in UK families with ALS. J Neurol Sci. 1999;169: 56–60.
   PubMedGoogle Scholar
• Banci L, Bertini I, Durazo A, Girotto S, Gralla EB, Martinelli M, . Metal-free superoxide dismutase forms soluble oligomers under physiological conditions: a possible general mechanism for familial ALS. Proc Natl Acad Sci USA. 2007;104:11263–7.
   PubMedGoogle Scholar
• Cozzolino M, Amori I, Pesaresi MG, Ferri A, Nencini M, Carrí MT. Cysteine 111 affects aggregation and cytotoxicity of mutant Cu/Zn superoxide dismutase associated with familial amyotrophic lateral sclerosis. J Biol Chem. 2008; 283:866–74.
   PubMed Web of Science ®Google Scholar
• Niwa J, Yamada S, Ishigaki S, Sone J, Takahashi M, Katsuno M, . Disulfide bond mediates aggregation, toxicity, and ubiquitylation of familial amyotrophic lateral sclerosis-linked mutant SOD1. J Biol Chem. 2007; 282:28087–95.
   PubMed Web of Science ®Google Scholar
• Karch CM, Borchelt DR. A limited role for disulfide cross-linking in the aggregation of mutant SOD1 linked to familial amyotrophic lateral sclerosis. J Biol Chem. 2008;283: 13528–37.
   PubMed Web of Science ®Google Scholar
• Wang J, Slunt H, Gonzales V, Fromholt D, Coonfield M, Copeland NG, . Copper-binding-site-null SOD1 causes ALS in transgenic mice: aggregates of non-native SOD1 delineates a common feature. Hum Mol Genet. 2003;12: 2753–64.
   PubMed Web of Science ®Google Scholar
• Watanabe S, Nagano S, Duce J, Kiaei M, Li QX , Tucker SM, . Increased affinity for copper mediated by cysteine 111 in forms of mutant superoxide dismutase-1 linked to amyotrophic lateral sclerosis. Free Radic Biol Med. 2007; 42:1534–42.
   PubMed Web of Science ®Google Scholar